Study details
Enrolling now
Using New Blood Tests to Identify Long COVID
MaxWell Clinic, PLC
NCT IDNCT06311435ClinicalTrials.gov data as of Apr 2026
Target enrollment
224
Study length
about 2 years
Ages
18+
Locations
2 sites in IA, TN
About this study
This trial is testing if a new blood test can help identify people with long COVID. The test looks at RNA in the blood, and researchers are comparing it to healthy individuals and other conditions that cause similar symptoms. This will determine if this test can accurately distinguish between these groups.
Based on ClinicalTrials.gov records.
What participants do
- 1.RNA Biomarker Blood Test
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low5%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Procedures
diagnostic